Nalidixic acid

This MedLibrary.org supplementary page on Nalidixic acid is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Nalidixic acid
Systematic (IUPAC) name
1-ethyl-7-methyl-4-oxo-[1,8]naphthyridine-3-carboxylic acid
Identifiers
CAS number 389-08-2
ATC code J01MB02
PubChem 4421
DrugBank APRD01133
Chemical data
Formula C12H12N2O3 
Mol. mass 232.235 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding 90%
Metabolism Partially Hepatic
Half life 6-7 hours, significantly longer in renal impairment
Excretion  ?
Therapeutic considerations
Pregnancy cat.

B U.S.

Legal status
Routes Oral

Nalidixic acid (tradenames Neggram and Wintomylon) is the basis for quinolone antibiotics.

Nalidixic acid is effective against both gram-positive and gram-negative bacteria. In lower concentrations, it acts in a bacteriostatic manner; that is, it inhibits growth and reproduction. In higher concentrations, it is bactericidal, meaning that it kills bacteria instead of merely inhibiting their growth.

It is especially used in treating urinary tract infections, caused, for example, by Escherichia coli, Proteus, Shigella, Enterobacter, and Klebsiella.. It is also a tool in studies as a regulation of bacterial division. It selectively and reversibly blocks DNA replication in susceptible bacteria. Nalidixic acid and related antibiotics inhibit a subunit of DNA gyrase and induce formation of relaxation complex analogue. It also inhibits the nicking dosing activity on the subunit of DNA gyrase that release the positive binding stress on on the supercoiled DNA.

External links

See also

Wikipedia content modification information:

  • This page was last modified on 23 April 2008, at 02:16.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Nalidixic acid".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.